Sign in

CIK 0001787306

  • Large accelerated filer

Arcutis Biotherapeutics, Inc.

Sign in to watch
Ticker
ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812974255
Phone
+1 805-418-5006
Business address
3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
Former names
Arcutis, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,253,826
in 9 filings, $2.1M under 10b5-1 plans

Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-04 Watanabe Todd Franklin Sale 10b5-1 −14,903 $11.12 $166K 874,533
2024-03-04 Moore Matthew Richard SVP and Chief Business Officer Sale 10b5-1 −3,468 $11.12 $39K 146,020
2024-03-04 Heron Patrick J Director Purchase +21,052 $9.50 $200K 8,785,284
2024-02-28 Watanabe Todd Franklin Sale 10b5-1 −2,465 $10.60 $26K 889,436
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Grant or award +26,666 81,256
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Grant or award +26,666 107,922
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Grant or award +17,650 125,572
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Grant or award +19,750 145,322
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Grant or award +4,166 149,488
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Returned to the company · Stock Option (Right to Buy) −80,000 0
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Returned to the company · Stock Option (Right to Buy) −80,000 0
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Returned to the company · Stock Option (Right to Buy) −35,300 0
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Returned to the company · Stock Option (Right to Buy) −39,500 0
2024-02-13 Moore Matthew Richard SVP and Chief Business Officer Returned to the company · Stock Option (Right to Buy) −12,500 0
2024-02-13 Burnett Patrick Grant or award +128,000 213,032
2024-02-13 Burnett Patrick Grant or award +9,600 222,632
2024-02-13 Burnett Patrick Grant or award +23,550 246,182
2024-02-13 Burnett Patrick Grant or award +27,900 274,082
2024-02-13 Burnett Patrick Returned to the company · Stock Option (right to buy) −320,000 0
2024-02-13 Burnett Patrick Returned to the company · Stock Option (right to buy) −28,800 0

Page 20 of 35 · 689 trades